European Archives - Page 223 of 1177 - European Medical Journal

Could GLP-1 Drugs Reduce Alcohol Consumption?

A systematic review investigating the impact of glucagon-like peptide-1 receptor agonists on alcohol consumption has yielded some promising results.

Efficacy of Dupilumab in Children with Atopic Dermatitis

At week 16, dupilumab demonstrated significant benefits compared to placebo, regardless of the presence of asthma or AR.

Donald Trump picks last role in health leadership team

President-elect Donald Trump has picked the final post in his health team, selecting Dr Jay Bhattacharya to be Director of the US National Institutes of Health.

Systemic Inflammation Links Psoriasis Severity to Cardiovascular Disease

Systemic inflammation mediates psoriasis severity’s link to cardiovascular disease, highlighting its importance in clinical care.

Combining Therapies Boosts Survival in Bladder Cancer

Predictive biomarkers are expected to play a pivotal role in further enhancing treatment outcomes as they can identify patients at higher risk of recurrence.

Hema Now: Episode 5: The Hidden Impact of Blood Disorders on Brain Health

In this episode of Hema Now, Jonathan Sackier welcomes Christopher Patriquin, a leading expert in the field of hematology and rare diseases. With a wealth of experience in teaching, consulting, clinical research, and hosting excellent dinner parties, Patriquin’s discussion sheds light on many fascinating topics.

Nicotinamide Riboside Reduces Airway Inflammation in Patients With COPD

Nicotinamide riboside reduces airway inflammation and boosts NAD+ levels in COPD patients, study shows.

Climate Change Drives Increased Use of Medical Imaging in Emergency Departments

Study finds air pollution linked to increased use of medical imaging in emergency departments.

New Insights on Embolisation for Managing Subdural Haematomas

Middle meningeal artery embolisation lowers adverse events but shows no clear advantage in preventing subdural hematoma recurrence.

Fostering trust between pharma and HCPs

This infographic explores the state of trust between the healthcare and pharmaceutical industries, assessing where they stand in the rankings, how valuable pharma-HCP interactions can be and more.